-T807 has demonstrated a propensity of the ligand to bind to the SN and GP in what appears to be a non-specific fashion (http:// www.alzforum.org/news/conference-coverage/tau-tracers-shineboston-conference). The [18F]-T807 binding to the hippocampi in 1 could fall within the spectrum of aging-related tauopathy, the known deposition of NFT in this region (http://www.alzforum.org/ news/conference-coverage/tau-tracers-shine-bostonconference). We write here to emphasize the point that proof of the histological underpinnings of [18F]-T807 binding awaits the presentation of a sufficiently powered study of in vivo-radiological/postmortemhistological correlation relationships, and as a reminder that while the development of several putative tau-binding ligands has opened new possibilities for research and clinical use, that none have been validated to the extent necessary for reliable use and such validation should be a top priority.
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